NCT05418959Enrolling by invitationPhase 1
Genetic Risk Stratification of Pediatric Skin Lesions
Source: ClinicalTrials.gov · Last updated 22 May 2026
Brief summary (registry, in English)
A study to understand the clinical utility of noninvasive adhesive skin biopsies in pediatric patients by exploring whether DermTech Pigmented Lesion Assay (PLA) genetic risk analysis of suspicious lesions in children correlates with histopathological diagnosis.
- Status (registry)
- Enrolling by invitation
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- First submitted
- 9 Jun 2022
- Start date
- 1 Aug 2022
- Primary completion date
- 1 Jan 2028
- Lead sponsor
- Massachusetts General Hospital
- NCT number
- NCT05418959
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 100
- From 1 Aug 2022 to the primary completion date, 1 Jan 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previously biopsied, scarred, or known melanoma lesions
Other illness
- Bleeding or ulcerated lesions
- Presence of active psoriasis/eczema/other skin condition in area to be biopsied
Other
- Lesions on palms, soles, mucosal membranes, or area where hair cannot be trimmed
Who the study is looking for
- 20 years of age or younger.
- Subjects or parents willing and able to give informed consent, and assent as appropriate
- Patients will have one or more atypical skin lesions with management plan of monitoring, surgical biopsy, and/or excision of atypical nevi within the next 6 months
Age in the registry: 0 years to 20 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| MGH Dermatology Coordinator of this site? Confirm its status | Boston | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.